Malignant Oral Cavity Neoplasm — Trials

Malignant Oral Cavity Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

379 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 111
Recruiting: 57
Ph III recruiting: 9
Growth YoY: +11.5%
Industry share: 6%
Top sponsor: National Cancer Institute (NCI)
Termination share: 31.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (45)

clinicaltrialsPublishedShowing 51–100 of 145 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07254962	CApecitabine Prior to TUmor Resection in Ent Oncology (CAPTURE)(CAPTURE)	not yet recruiting	Phase 2	75	Sir Mortimer B. Davis - Jewish General HospitalOTHER	0	Nov 28, 2025	clinicaltrials
NCT03021993	Trial of Nivolumab as a Novel Neoadjuvant Pre-Surgical Therapy for Locally Advanced Oral Cavity Cancer	completed	Phase 2	17	Medical University of South CarolinaOTHER	1	Nov 12, 2025